PharmaCielo Struggles To Complete Financing, Extends Closing To March

It appears that PharmaCielo (TSXV: PCLO) is having a difficult time raising funds for its operations. The firm this morning announced further delays to the final closing of a financing announced in December.

The company is currently looking to raise $15.0 million from the sale of debenture units in a non-brokered offering. The units bear interest at a rate of 11% per annum, are valid for three years, and contain 250 common share purchase warrants. Warrants are valid for a period of 36 months, and contain a maturity of 50% over the offering price at the time of the initial closing. Debt under the offering is secured by the assets of the company.

Originally estimating to sell 15,000 units at $1,000 per each, the firm expected to close the offering on December 30, with proceeds being used for operations, working capital, and the build-out of its dry flower sales program.

However, the firm managed to close just $5.0 million in gross proceeds on December 31, which included a portion of insider participation.

The remaining portion of the financing however is now not expected to close until March 4, pending ongoing discussions with certain parties.

PharmaCielo last traded at $1.07 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

PharmaCielo Looks To Raise $15.0 Million Via 11% Secured Debentures

PharmaCielo (TSXV: PCLO) is returning to the trough for more investor dollars. The firm this...

Wednesday, December 22, 2021, 08:14:04 AM

Drug Trade: The Three Basic Cannabis Health Company Archetypes

The popular belief that cannabis will work its way further into mainstream culture and further...

Saturday, December 21, 2019, 08:00:00 AM

PharmaCielo Receives Approval For US$3 Million Import Contract

PharmaCielo Ltd (TSXV: PCLO) has become one of the first venture listed equities to receive...

Friday, January 17, 2020, 09:02:20 AM

PharmaCielo Enters Supply Agreement With Xphyto Therapeutics

PharmaCieolo Ltd. (TSXV: PCLO) has announced a supply agreement with Xphyto Therapeutics Corp (CSE: XPHY)....

Monday, January 27, 2020, 11:04:28 AM

PharmaCielo Conducts $4.0 Million Bought Deal Financing

PharmaCielo Ltd (TSXV: PCLO) is the latest firm to announce a bought deal financing. The...

Wednesday, June 10, 2020, 08:32:24 AM